<DOC>
	<DOCNO>NCT01166633</DOCNO>
	<brief_summary>Statin effective drug treat hyperlipidemia ( hypercholesterolemia ) , rarely lead hepatic damage patient hepatic disorder . For patient , intensive monitoring require .</brief_summary>
	<brief_title>Efficacy Safety Study Pitavastatin Versus Atorvastatin Treat Hypercholesterolemia</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Pitavastatin</mesh_term>
	<mesh_term>Hydroxymethylglutaryl-CoA Reductase Inhibitors</mesh_term>
	<criteria>Patients age 25 75 Patients sign informed consent form volition ; Patients take statins 2 month longer whose fast LDLC level , 130mg/dL ( Friedewald 's formula ) ; Patients whose ALT level 1.25 2.5 time high upper limit normal Patients uncompensated liver cirrhosis . Patients whose total bilirubin level 2 time high upper limit normal . Patients take antiviral drug viral hepatitis . Patients experience cerebrovascular disease myocardial infarction within 3 month screen visit patient heart failure ( NYHA class IV ) . Patients whose triglyceride ( TG ) level 400mg/dL high . Patients uncontrolled hypertension ( DBP≧100mmHg ) Patients suspicion renal dysfunction ( serum creatinine≧2.0mg/dL ) Patients whose CK level 2.5 time high upper limit normal . Patients uncontrolled hypothyroidism although drug treatment ( TSH≧ULN×1.5 ) Female patient nurse pregnant plan become pregnant . Patients judge unsuitable investigator .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Hydroxymethylglutaryl-CoA Reductase Inhibitors</keyword>
	<keyword>hyperlipidemia</keyword>
</DOC>